Form 4 Tracker
Ryan Cohlhepp

Director, President and COO; Director, President, COO & Interim CEO · 11 filings · Latest: Sep 8, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Ryan CohlheppDirector, President, COO & Interim CEOSep 8, 2026
Sale
$22.9017,500$400.7K181,641
BCAX
Ryan CohlheppDirector, President, COO & Interim CEOSep 8, 2026
Option Exercise
$3.7917,500$66.3K199,141
BCAX
Cohlhepp Ryan—Sep 8, 2026
Proposed Sale
$22.6417,500$396.2K—
BCAX
Ryan CohlheppDirector, President and COOAug 10, 2026
Sale
$27.9818,750$524.5K181,641
BCAX
Ryan CohlheppDirector, President and COOAug 10, 2026
Option Exercise
$3.7918,750$71.1K200,391
BCAX
Cohlhepp Ryan—Aug 10, 2026
Proposed Sale
$27.8318,750$521.8K—
BCAX
Ryan CohlheppDirector, President and COOJul 9, 2026
Sale
$29.00536$15.5K181,641
BCAX
Ryan CohlheppDirector, President and COOJul 8, 2026
Sale
$28.9828,214$817.6K182,177
BCAX
Ryan CohlheppDirector, President and COOJul 8, 2026
Option Exercise
$3.7918,750$71.1K210,391
BCAX
Cohlhepp Ryan—Jul 8, 2026
Proposed Sale
$30.2528,750$869.7K—
BCAX
Ryan CohlheppDirector, President and COOMay 15, 2026
Sale
$20.2912,500$253.6K191,641
BCAX
Ryan CohlheppDirector, President and COOMay 15, 2026
Option Exercise
$3.798,000$30.3K204,141
BCAX
Cohlhepp Ryan—May 15, 2026
Proposed Sale
$20.3112,500$253.9K—
BCAX
Ryan CohlheppDirector, President and COOApr 15, 2026
Sale
$23.0112,500$287.6K196,141
BCAX
Ryan CohlheppDirector, President and COOApr 15, 2026
Option Exercise
$3.798,000$30.3K208,641
BCAX
Cohlhepp Ryan—Apr 15, 2026
Proposed Sale
$22.9812,500$287.3K—
BCAX
Ryan CohlheppDirector, President and COOMar 16, 2026
Sale
$19.6612,500$245.7K200,641
BCAX
Ryan CohlheppDirector, President and COOMar 16, 2026
Option Exercise
$3.798,000$30.3K213,141
BCAX
Cohlhepp Ryan—Mar 16, 2026
Proposed Sale
$19.3412,500$241.8K—
BCAX
Ryan CohlheppDirector, President and COOMar 3, 2026
Sale
$18.1617,392$315.9K205,141

Page 1 of 2

Next →